The Blood Grouping Reagents Market in Brazil exhibited a general trend of contraction between 2013 and 2023, where it stood at 35.183 million US dollars. The market showed notable fluctuations but was dominantly on a declining path, with a Compound Annual Growth Rate (CAGR) of -3.78% over the last five years. Specifically, the market experienced a year-on-year decrease of 3.18% in 2023. Looking forward, forecasts indicate the market will decrease to 29.569 million US dollars by 2028, reflecting an even sharper five-year CAGR of -2.78% and a forecasted overall decline of 13.13% from 2024 to 2028.

Future trends to watch for include:

Technological advancements in diagnostic techniques, which might impact the demand for traditional blood grouping reagents.
Potential regulatory changes that could either hinder or support market growth.
Emerging markets or segments within Brazil that could influence overall market dynamics.